Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by José Manuel Puerta
Feasibility of Treatment Discontinuation in Chronic Myeloid Leukemia in Clinical Practice: Results From a Nationwide Series of 236 Patients
Blood Cancer Journal
Oncology
Hematology
Related publications
Discontinuation of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: Recommendations for Clinical Practice From the French Chronic Myeloid Leukemia Study Group
Cancer
Cancer Research
Oncology
Future Perspectives of Tyrosine Kinase Inhibitors Discontinuation in Chronic Myeloid Leukemia
Chemotherapy: Open Access
Successful Delivery After Planned Discontinuation of Imatinib in a Patient With Chronic Myeloid Leukemia
Internal Medicine
Internal Medicine
Medicine
Treatment of Chronic Myeloid Leukemia With Generic Imatinib in Patients From Northeastern Part of India
International Journal of Research in Pharmaceutical Sciences
Toxicology
Pharmaceutics
Pharmacology
Satisfaction With Information on Nilotinib Treatment in Chronic Myeloid Leukemia Patients
Acta Oncologica
Nuclear Medicine
Radiology
Hematology
Oncology
Medicine
Imaging
Current Information and Recommendations on the Discontinuation of TKI Inhibitors in Chronic Myeloid Leukemia
Current Oncology Reports
Oncology
Molecular Monitoring of Therapeutic Milestones and Clinical Outcomes in Patients With Chronic Myeloid Leukemia
Cancer
Cancer Research
Oncology
Treatment-Related Acute Myeloid Leukemia in a Chronic Lymphocytic Leukemia Patient: Role of Fludarabine?
Therapeutic Advances in Hematology
Hematology
Dasatinib in the Treatment of Imatinib Refractory Chronic Myeloid Leukemia
Biologics: Targets and Therapy
Oncology
Immunology
Gastroenterology
Pharmacology
Rheumatology
Allergy
